固有免疫细胞治疗联合肿瘤特异性抗体与放疗在胰腺癌模型中激发抗肿瘤应答

Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models.

胰腺癌新兴嵌合抗原受体免疫细胞治疗：机制、临床进展与未来展望

Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives.

CAR-T 细胞治疗胰腺癌：当前证据综述

Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence.

CAR-NK 细胞联合 CAR-巨噬细胞治疗胰腺癌的协同抗肿瘤活性

Synergistic antitumor activity of CAR-NK cells combined with CAR-macrophages for pancreatic cancer treatment.

基于纳米抗体的 CAR-M 与 CAR-NK 联合疗法重编程 TME，并在巨噬细胞与 NK 细胞之间建立起由 CXCL9 驱动的前馈环路，从而产生协同的固有免疫激活和强效的肿瘤控制。

益生菌在增强免疫功能与提高胰腺癌治疗效果中的作用

Role of Probiotics in Enhancing Immune Function and Improving the Effectiveness of Treatments for Pancreatic Cancer.

复发性终末期胰腺癌经 α-半乳糖神经酰胺树突状细胞疫苗、Wilms 瘤 1 树突状细胞疫苗和 NK 细胞疗法联合免疫细胞治疗后完全缓解

Complete Response in Recurrent End-Stage Pancreatic Cancer After Combined Immune Cell Therapy of α-Galactosylceramide Dendritic Cell Vaccine Therapy,

STING 激动剂 cGAMP 增强 CAR-NK 细胞抗胰腺癌的抗肿瘤活性

STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer.

靶向 EGFR 的 IgG1 抗体增强 KRAS 突变胰腺癌中 NK 细胞介导的肿瘤杀伤

EGFR-Targeting IgG1 Antibody Enhances NK Cell-Mediated Tumor Killing in KRAS-Mutant Pancreatic Cancer.

TROP2-CAR-NK（CAR-NK 细胞）治疗胰腺癌、卵巢癌：I/II 期临床试验

Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian

这是一项 I/II 期注册临床试验，评估 CAR-NK 细胞治疗胰腺癌、卵巢癌的安全性、可行性及初步疗效。当前状态：进行中（不再招募）。计划入组 51 例。试验地点：美国 · 休斯顿（共 1 个中心）。登记号：NCT05922930。

NK 细胞用于胰腺癌免疫治疗：纳米颗粒的作用

Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles.